Novel biomarker derived from EBV promising for mass screening for nasopharyngeal cancer: NEJM

China: A recent study has shown anti–BNLF2b total antibody (P85-Ab) to be a promising novel biomarker for screening of nasopharyngeal carcinoma, with higher specificity, sensitivity, and positive...

Related Keywords

Xiamen ,Fujian ,China ,Zhongshan ,Anhui ,Ningshao Xia ,Key Laboratory Of Vaccines ,Xiamen University ,State Key Laboratory ,Infectious Diseases ,Epstein Barr Virus ,Mass Screening ,New England Journal Of Medicine ,Nasopharyngeal Cancer ,Biomarker ,Cancer Screening ,Ntibody ,Screening ,Dancer ,85 Ab ,Novel Biomarker ,Sensitivity ,Specificity ,